Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40%, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including; poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components; service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)20-30
Number of pages11
JournalLiver International
Volume39
Issue number1
Early online date29 Aug 2018
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Hepatitis C
Health
Pharmaceutical Preparations
Healthcare Financing
Health Information Systems
Harm Reduction
Health Manpower
Aftercare
Federal Government
Infection
Hepatitis
Health Services
Therapeutics
Public Health
Communication
Population

Keywords

  • elimination
  • health systems
  • people who inject drugs
  • viral hepatitis C

Cite this

@article{8853d339fa964ebeb02993bfb2255789,
title = "Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework",
abstract = "The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40{\%}, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including; poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components; service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework. This article is protected by copyright. All rights reserved.",
keywords = "elimination, health systems, people who inject drugs, viral hepatitis C",
author = "Emma Day and Margaret Hellard and Carla Treloar and Julie Bruneau and Martin, {Natasha K.} and Anne {\O}vrehus and Olav Dalgard and Andrew Lloyd and John Dillon and Matt Hickman and Jude Byrne and Alain Litwin and Mojca Maticic and Philip Bruggmann and Havard Midgard and Brianna Norton and Stacey Trooskin and Lazarus, {Jeffrey V.} and Jason Grebely",
note = "This article is protected by copyright. All rights reserved.",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/liv.13949",
language = "English",
volume = "39",
pages = "20--30",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley",
number = "1",

}

TY - JOUR

T1 - Hepatitis C elimination among people who inject drugs

T2 - Challenges and recommendations for action within a health systems framework

AU - Day, Emma

AU - Hellard, Margaret

AU - Treloar, Carla

AU - Bruneau, Julie

AU - Martin, Natasha K.

AU - Øvrehus, Anne

AU - Dalgard, Olav

AU - Lloyd, Andrew

AU - Dillon, John

AU - Hickman, Matt

AU - Byrne, Jude

AU - Litwin, Alain

AU - Maticic, Mojca

AU - Bruggmann, Philip

AU - Midgard, Havard

AU - Norton, Brianna

AU - Trooskin, Stacey

AU - Lazarus, Jeffrey V.

AU - Grebely, Jason

N1 - This article is protected by copyright. All rights reserved.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40%, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including; poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components; service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework. This article is protected by copyright. All rights reserved.

AB - The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40%, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including; poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components; service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework. This article is protected by copyright. All rights reserved.

KW - elimination

KW - health systems

KW - people who inject drugs

KW - viral hepatitis C

U2 - 10.1111/liv.13949

DO - 10.1111/liv.13949

M3 - Article

C2 - 30157316

VL - 39

SP - 20

EP - 30

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 1

ER -